补体系统在膜性肾病发病机制中的研究进展
Advances in the Study of Complement System in Pathogenesis of Membranous Nephropathy
DOI: 10.12677/ACM.2021.112096, PDF,   
作者: 谭力文, 王 墨*:重庆医科大学附属儿童医院肾内科,儿童发育疾病研究教育部重点实验室,国家儿童健康与疾病临床医学研究中心,儿童发育重大疾病国家国际科技合作基地重庆,儿科学重庆市重点实验室,重庆
关键词: 补体系统膜性肾病发病机制Complement System Membranous Nephropathy Pathogenesis
摘要: 膜性肾病是成人肾病综合征最常见的病理类型之一,在儿童中的发病率也逐年升高,其典型病理表现为肾小球脏层上皮细胞下免疫复合物沉积。免疫复合物可激活补体系统,最终形成膜攻击复合物,导致肾脏损伤。目前关于补体系统在膜性肾病的发病机制中的具体作用不详,本文将从动物实验、补体系统激活、补体系统调节等几方面阐述膜性肾病的发病机制研究进展。
Abstract: Membranous nephropathy is one of the most common pathological types of nephrotic syndrome in adults, and the incidence of membranous nephropathy is increasing in recent years. The typical pathological manifestation of membranous nephropathy is immune complex deposition under the podocyte cells. The immune complex activates the complement system and forms the membrane attack complex. Finally, the membrane attack complex leads to kidney injury. At present, the specific role of the complement system in the pathogenesis of membranous nephropathy is unknown. This article will discuss the advances in the study of the complement system in the pathogenesis of membranous nephropathy from animal experiments, complement system activation, and complement system regulation.
文章引用:谭力文, 王墨. 补体系统在膜性肾病发病机制中的研究进展[J]. 临床医学进展, 2021, 11(2): 662-668. https://doi.org/10.12677/ACM.2021.112096

参考文献

[1] Nie, S., He, W., Huang, T., et al. (2018) The Spectrum of Biopsy-Proven Glomerular Diseases among Children in China: A National, Cross-Sectional Survey. Clinical Journal of the American Society of Nephrolog, 13, 1047-1054. [Google Scholar] [CrossRef
[2] Reinhard, L., Stahl, R.A.K. and Hoxha, E. (2020) Is Primary Membranous Nephropathy a Complement Mediated Disease? Molecular Immunology, 128, 195-204. [Google Scholar] [CrossRef] [PubMed]
[3] Ravindran, A., Madden, B., Charlesworth, M.C., et al. (2020) Proteomic Analysis of Complement Proteins in Membranous Nephropathy. Kidney International Reports, 5, 618-626. [Google Scholar] [CrossRef] [PubMed]
[4] Oto, O.A., Demir, E., Mirioglu, S., et al. (2021) Clinical Significance of Glomerular C3 Deposition in Primary Membranous Nephropathy. Journal of Nephrology. [Google Scholar] [CrossRef] [PubMed]
[5] Hajishengallis, G., Reis, E.S., Mastellos, D.C., et al. (2017) Novel Mechanisms and Functions of Complement. Nature Immunology, 18, 1288-1298. [Google Scholar] [CrossRef] [PubMed]
[6] Arbore, G., Kemper, C. and Kolev, M. (2017) Intracellular Complement—The Complosome—In Immune Cell Regulation. Molecular Immunology, 89, 2-9. [Google Scholar] [CrossRef] [PubMed]
[7] Walport, M.J. (2001) Complement. First of Two Parts. The New England Journal of Medicine, 344, 1058-1066. [Google Scholar] [CrossRef
[8] Hajishengallis, G., Kajikawa, T., Hajishengallis, E., et al. (2019) Complement-Dependent Mechanisms and Interventions in Periodontal Disease. Frontiers in Immunology, 10, 406. [Google Scholar] [CrossRef] [PubMed]
[9] Menny, A., Serna, M., Boyd, C.M., et al. (2018) CryoEM Reveals How the Complement Membrane Attack Complex Ruptures Lipid Bilayers. Nature Communications, 9, 5316. [Google Scholar] [CrossRef] [PubMed]
[10] Hayashi, N., Okada, K., Matsui, Y., et al. (2018) Glomerular Mannose-Binding Lectin Deposition in Intrinsic Antigen-Related Membranous Nephropathy. Nephrology Dialysis Transplantation, 33, 832-840. [Google Scholar] [CrossRef] [PubMed]
[11] Heymann, W., Hackel, D.B., Harwood, S., et al. (2000) Production of Nephrotic Syndrome in Rats by Freund’s Adjuvants and Rat Kidney Suspensions. 1951. Journal of the American Society of Nephrology, 11, 183-188.
[12] Akiyama, S., Imai, E. and Maruyama, S. (2019) Immunology of Membranous Nephropathy. F1000Research, 8, 734. [Google Scholar] [CrossRef] [PubMed]
[13] Ronco, P. and Debiec, H. (2017) A Podocyte View of Membranous Nephropathy: From Heymann Nephritis to the Childhood Human Disease. Pflügers Archiv, 469, 997-1005. [Google Scholar] [CrossRef] [PubMed]
[14] Couser, W.G. (2017) Primary Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 12, 983-997. [Google Scholar] [CrossRef
[15] Schiller, B., He, C., Salant, D.J., et al. (1998) Inhibition of Complement Regulation Is Key to the Pathogenesis of Active Heymann Nephritis. Journal of Experimental Medicine, 188, 1353-1358. [Google Scholar] [CrossRef] [PubMed]
[16] Salant, D.J. (2019) Unmet Challenges in Membranous Nephropathy. Current Opinion in Nephrology and Hypertension, 28, 70-76. [Google Scholar] [CrossRef
[17] Meyer-Schwesinger, C., Tomas, N.M., Dehde, S., et al. (2020) A Novel Mouse Model of Phospholipase A2 Receptor 1-Associated Membranous Nephropathy Mimics Podocyte Injury in Patients. Kidney International, 97, 913-919. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, M.-F., Cui, Z., Zhang, Y.-M., et al. (2018) Clinical and Prognostic Significance of Glomerular C1q Deposits in Primary MN. Clinica Chimica Acta, 485, 152-157. [Google Scholar] [CrossRef] [PubMed]
[19] Sethi, S., Madden, B.J., Debiec, H., et al. (2019) Exostosin 1/Exostosin 2-Associated Membranous Nephropathy. Journal of the American Society of Nephrology, 30, 1123-1136. [Google Scholar] [CrossRef
[20] Vivarelli, M., Emma, F., Pellé, T., et al. (2015) Genetic Homogeneity but IgG Subclass-Dependent Clinical Variability of Alloimmune Membranous Nephropathy with Anti-Neutral Endopeptidase Antibodies. Kidney International, 87, 602-609. [Google Scholar] [CrossRef] [PubMed]
[21] Bally, S., Debiec, H., Ponard, D., et al. (2016) Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency. Journal of the American Society of Nephrology, 27, 3539-3544. [Google Scholar] [CrossRef
[22] Zhang, M.-F., Huang, J., Zhang, Y.-M., et al. (2019) Complement Activation Products in the Circulation and Urine of Primary Membranous Nephropathy. BMC Nephrology, 20, 313. [Google Scholar] [CrossRef] [PubMed]
[23] Wiech, T., Stahl, R.A.K. and Hoxha, E. (2019) Diagnostic Role of Renal Biopsy in PLAR1-Antibody-Positive Patients with Nephrotic Syndrome. Modern Pathology, 32, 1320-1328. [Google Scholar] [CrossRef] [PubMed]
[24] Sinico, R.A., Mezzina, N., Trezzi, B., et al. (2016) Immunology of Membranous Nephropathy: From Animal Models to Humans. Clinical & Experimental Immunology, 183, 157-165. [Google Scholar] [CrossRef] [PubMed]
[25] Haddad, G., Lorenzen, J.M., Ma, H., et al. (2020) Altered Glycosylation of IgG4 Promotes Lectin Complement Pathway Activation in Anti-PLA2R1 Associated Membranous Nephropathy. Journal of Clinical Investigation. [Google Scholar] [CrossRef
[26] Luo, W., Olaru, F., Miner, J.H., et al. (2018) Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy. Frontiers in Immunology, 9, 1433. [Google Scholar] [CrossRef] [PubMed]
[27] Thurman, J.M. (2020) Complement and the Kidney: An Overview. Advances in Chronic Kidney Disease, 27, 86-94. [Google Scholar] [CrossRef] [PubMed]
[28] Mutti, M., Ramoni, K., Nagy, G., et al. (2018) A New Tool for Complement Research: Reconstituted Human Classical Complement Pathway. Frontiers in Immunology, 9, 2770. [Google Scholar] [CrossRef] [PubMed]
[29] Moll, S., Lange, S., Mihatsch, M.J., et al. (2006) CRIT Is Expressed on Podocytes in Normal Human Kidney and Upregulated in Membranous Nephropathy. Kidney International, 69, 1961-1968. [Google Scholar] [CrossRef] [PubMed]
[30] Angeletti, A., Cantarelli, C., Petrosyan, A., et al. (2020) Loss of Decay-Accelerating Factor Triggers Podocyte Injury and Glomerulosclerosis. Journal of Experimental Medicine, 217, e20191699. [Google Scholar] [CrossRef] [PubMed]
[31] Moll, S., Miot, S., Sadallah, S., et al. (2001) No Complement Receptor 1 Stumps on Podocytes in Human Glomerulopathies. Kidney International, 59, 160-168. [Google Scholar] [CrossRef] [PubMed]
[32] Seikrit, C., Ronco, P. and Debiec, H. (2018) Factor H Autoantibodies and Membranous Nephropathy. The New England Journal of Medicine, 379, 2479-2481. [Google Scholar] [CrossRef
[33] Lehto, T., Honkanen, E., Teppo, A.M., et al. (1995) Urinary Excretion of Protectin (CD59), Complement SC5b-9 and Cytokines in Membranous Glomerulonephritis. Kidney International, 47, 1403-1411. [Google Scholar] [CrossRef] [PubMed]